documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
7 rows where docket_id = "FDA-1996-N-0006" and posted_year = 2008 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1996-N-0006-0024 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Letter from Rural Industries Research & Development Corporation (RIRDC) to FDA/CDER | Other | Letter(s) | 2008-08-27T04:00:00Z | 2008 | 8 | 2008-08-27T04:00:00Z | 2015-03-20T14:44:40Z | 0 | 0 | 09000064804f997d | ||
| FDA-1996-N-0006-0025 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Letter from Thursday Plantation Laboratories Limited to FDA/CDER | Other | Letter(s) | 2008-08-27T04:00:00Z | 2008 | 8 | 2008-08-27T04:00:00Z | 2015-03-19T19:28:39Z | 0 | 0 | 09000064804f997f | ||
| FDA-1996-N-0006-0027 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Response Letter from FDA/CDER to Haarmann & Reimer Corporation [McKenna Comer & Cuneo] | Other | Letter(s) | 2008-08-27T04:00:00Z | 2008 | 8 | 2008-08-27T04:00:00Z | 2015-03-19T19:39:06Z | 0 | 0 | 09000064804f996a | ||
| FDA-1996-N-0006-0022 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Letter from FDA/CDER to European-American Phytomedicines Coalition [Akin, Gump, Strauss, Hauer & Feld, LLP] | Other | Letter(s) | 2008-08-27T04:00:00Z | 2008 | 8 | 2008-08-27T04:00:00Z | 2015-06-19T20:52:14Z | 0 | 0 | 09000064804f996c | ||
| FDA-1996-N-0006-0021 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Response from FDA/CDER to BASF AG [Morgan, Lewis & Bockius, LLP] | Other | Letter(s) | 2008-08-27T04:00:00Z | 2008 | 8 | 2008-08-27T04:00:00Z | 2015-03-19T20:02:36Z | 0 | 0 | 09000064804f996b | ||
| FDA-1996-N-0006-0026 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Letter from FDA CDER Response to RJR Consulting, Inc. | Other | Letter(s) | 2008-08-27T04:00:00Z | 2008 | 8 | 2008-08-27T04:00:00Z | 2015-06-19T20:54:39Z | 0 | 0 | 09000064806d87d0 | ||
| FDA-1996-N-0006-0023 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Supplement from Buchanan Ingersoll Attorneys | Other | Supplement (SUP) | 2008-08-27T04:00:00Z | 2008 | 8 | 2008-08-27T04:00:00Z | 2015-06-19T20:53:24Z | 0 | 0 | 09000064804f997b |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);